Metronidazole

CAS 443-48-1 4 current records 9 historicalSmall Molecule

Who holds supplier records for Metronidazole? 4 organisations hold a current record for Metronidazole: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Italy (1) and India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Metronidazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/metronidazole

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Metronidazole expires 4 Oct 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Metronidazole. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Metronidazole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Metronidazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2001-450 - Rev 11
Metronidazole
Jul 2026—
CORDEN PHARMA BERGAMO S.P.A. TreviglioIT
CEP 1995-052 - Rev 03
Metronidazole
Feb 2026Inspected Apr 2024
Italy
WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi CityCN
CEP 2024-218 - Rev 00
Metronidazole, Micronised
Jul 2024—
HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. Fengshan TownCN
CEP 2018-264 - Rev 02
Metronidazole, Process II
Mar 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Metronidazole are no longer active. These show a past filing, not current supply.

Show all 9 historical records
  • HUBEI HONGYUAN PHARMACEUTICAL CO LTD
    Inactive DMF 26658 · filed Nov 2012
  • China · Inactive DMF 19442 · filed Mar 2006
  • TIANJIN ZHONGAN PHARMACEUTICAL CO LTD
    Inactive DMF 16380 · filed Jan 2003
  • Poland · Inactive DMF 9294 · filed Aug 1991
  • TIANJIN HEBEI PHARMACEUTICAL FACTORY
    Inactive DMF 4927 · filed May 1983
  • MEDIMPEX NORTH AMERICA INC
    Inactive DMF 4672 · filed Oct 1982
  • India · Inactive DMF 3675 · filed Dec 1979
  • COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARL
    Inactive DMF 2186 · filed Nov 1973
  • RHONE POULENC INC
    Inactive DMF 780 · filed Feb 1964

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Metronidazole). The latest listed patent expires 4 Oct 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Metronidazole is a nitroimidazole antibiotic medication used for the treatment of anaerobic bacterial and protozoal infections. It acts by inhibiting nucleic acid synthesis by disrupting the DNA of microbial cells.

Chemical identity

IUPAC name
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
Canonical SMILES
CC1=NC=C(N1CCO)[N+](=O)[O-]
InChIKey
VAOCPAMSLUNLGC-UHFFFAOYSA-N
Synonyms
Flagyl API, metronidazole, Metronidazol, Gineflavir, 2-Methyl-5-nitroimidazole-1-ethanol, Deflamon, Orvagil, Anagiardil, Trichazol, MetroGel, Bayer 5360, Sanatrichom

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nitroimidazole Antimicrobial
Chemical structure
Nitroimidazoles

Therapeutic areas

AntibacterialAntiprotozoalAntimicrobial

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Metronidazole?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Metronidazole: CORDEN PHARMA BERGAMO SPA (Italy), Unichem Laboratories Ltd. (India), Wuhan Wuyao Pharmaceutical Co., Ltd. (China) and HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Metronidazole Drug Master Files are active?

CORDEN PHARMA BERGAMO SPA (DMF 3609) and Unichem Laboratories Ltd. (DMF 16263, 5783). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Metronidazole records mean?

9 organisations have only inactive Type II DMFs for Metronidazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Metronidazole have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Metronidazole on the EDQM register, including UNICHEM LABORATORIES LIMITED Mumbai (IN), CORDEN PHARMA BERGAMO S.P.A. Treviglio (IT), WUHAN WUYAO PHARMACEUTICAL CO., LTD. Huangshi City (CN) and HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD. Fengshan Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Metronidazole?

Yes. The latest patent listed for an approved US product containing Metronidazole expires 4 Oct 2039, across 59 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Metronidazole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Metronidazole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.